Sickness is not a good thing that is why there is a lot of medicine and treatments available for all types of ailments known to man. Sometimes the road to recovery for some ailments could be long and tedious depending on factors that affect the ailments. People get sick and they are unable to afford the right type of healthcare in other to facilitate healing or treatment. People also get sick and they have all the money in the world to afford any type of treatment available
What happens if you are born with sickness or if you are diagnosed with a sickness that requires $2 million united states dollars to purchase the medicine that you require for treatment?
This 2 million dollar dilemma is what the sickness called spinal Muscular Atrophy(SMA)brings. spinal muscular atrophy is a rare inherited sickness that stems from a defective gene that leads to the death of nerve cells responsible for moving muscles that allow us to walk, talk, breath, and swallow
This sickness can only be treated with a one-time intravenous shot of the gene therapy medicine Zolgensma. This medicine is manufactured by Novartis and it cost $2 million united states dollars
God have mercy on the broke man
Content created and supplied by: listener11 (via Opera News )
Opera News is a free to use platform and the views and opinions expressed herein are solely those of the author and do not represent, reflect or express the views of Opera News. Any/all written content and images displayed are provided by the blogger/author, appear herein as submitted by the blogger/author and are unedited by Opera News. Opera News does not consent to nor does it condone the posting of any content that violates the rights (including the copyrights) of any third party, nor content that may malign, inter alia, any religion, ethnic group, organization, gender, company, or individual. Opera News furthermore does not condone the use of our platform for the purposes encouraging/endorsing hate speech, violation of human rights and/or utterances of a defamatory nature. If the content contained herein violates any of your rights, including those of copyright, and/or violates any the above mentioned factors, you are requested to immediately notify us using via the following email address operanews-external(at)opera.com and/or report the article using the available reporting functionality built into our Platform See More